谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Efficacy and Safety of First-Line Bosutinib Versus Imatinib in the BFORE Trial: 18-Month Follow-up

R. E. Clark, C. Gambacorti-Passerini,M. Deininger,M. J. Mauro,C. Chuah,D. -W. Kim,I. Dyagil, N. Glushko,D. Milojkovic,P. Le Coutre,V. Garcia-Gutierrez, R. Crescenzo,E. Leip,N. Bardy-Bouxin,A. Hochhaus,T. H. Bruemmendorf,J. E. Cortes

BRITISH JOURNAL OF HAEMATOLOGY（2018）

引用 0|浏览41
暂无评分
关键词
Bosutinib,Chronic myeloid leukaemia,Clinical trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要